Executive Summary

Executive summary

But there is still an opportunity to substantially reduce the death toll by prioritising the most critical services, specifically antiretroviral therapy for HIV, timely TB diagnosis and treatment, and provision of long-lasting insecticide-treated nets for malaria, researchers say.

Executive summary

Tereza Kasaeva is to be the new Director of WHO's Global Tuberculosis (TB) Programme. She joins WHO from Russia's Ministry of Health. But instead of a warm welcome, she will arrive in Geneva amid potentially disabling controversy.

The Global Burden of Disease Study is the most comprehensive worldwide observational epidemiological study to date. It describes annually mortality and morbidity from major diseases, injuries and risk factors to health at global, regional and national levels.

The final results of a 4-year project to analyse the challenges and opportunities for health in sub-Saharan Africa are now published as a Lancet Commission — The Path to Longer and Healthier Lives for All Africans by 2030 — led by African physicians, health scientists, and policy makers.

Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves. The findings suggest that the UK's current pre-entry screening programme, now in place in 101 countries, as well as ongoing monitoring and treatment will be important in continuing the downward trend of TB incidence in the UK.

Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis.

The Lancet published a Series of five papers examining access to and sustainable effectiveness of antimicrobials.